You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 海吉亞醫療漲5% 獲公司高管增持 擬以1183.56萬元收購單縣海吉亞醫院餘下0.82%股權
格隆匯 12-24 10:26
格隆匯12月24日丨海吉亞醫療(6078.HK)盤中漲5.44%,報51.3港元,總市值317億港元。12月22日,海吉亞醫療獲公司創始人、控股股東、董事會主席兼CEO朱義文、執行董事兼高級副總裁任愛分別增持約38萬股和22萬股,共耗資逾2900萬港元。根據股權披露文件,自去年6月公司上市以來,朱義文已在二級市場四次增持公司股票,最新持股比例提升至45.48%。 作為腫瘤醫療服務龍頭,海吉亞醫療成長性持續兑現,近期受市場因素影響,公司股價已回調至年初低位。另外,海吉亞醫療於2021年12月21日,買方(海吉亞(上海)醫院管理有限公司,公司附屬)與賣方(菏澤開發區衞健醫療信息技術服務中心(有限合夥)、菏澤市吉祥康達醫療服務中心(有限合夥)、菏澤市海悦康健醫療服務中心(有限合夥))進一步訂立股權轉讓協議,賣方有條件同意出售目標醫院(單縣海吉亞醫院有限公司,公司附屬)合共約0.82%股權,總代價為人民幣1183.56萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account